ArticleBiophysical journal2026
Iomeprol X-ray contrast media alter conformation and affinity of the ATP binding pocket of actin.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast materials are widely used in various X-ray/CT and MRI diagnostic procedures. When administered in high volumes, contrast agents can strain kidney function and lead to acute renal failure. Contrast materials may damage the plasma membrane and penetrate into tissue cells. Some iodine-based contrast agents have been reported to distort the shape of red blood cells, implying a rearrangement of the actin cytoskeletal network. As actin plays a crucial role in numerous cellular processes, the effects of iodine-based contrast media on actin require clarification. We characterized the effect of iomeprol on the structure and function of actin using calorimetry, co-sedimentation, fluorescence spectroscopy, and molecular docking. Our results revealed that iomeprol disassembles the F-actin network by interacting with G-actin, suggesting a direct influence on its structural and functional properties. In line with this, polymerization and dilution-induced depolymerization assays, as well as critical concentration measurements, showed pronounced effects on actin dynamics. Iomeprol alters the conformation of G-actin, particularly the ATP-binding pocket-which becomes more open-and significantly (∼3-fold) decreases ATP affinity. Molecular docking supported these findings, indicating that iomeprol interacts with the ATP-binding cleft of G-actin. An additional interaction site was identified in the SD1/3 cleft-a known binding site for Wiskott-Aldrich syndrome protein and profilin-suggesting that iomeprol may also influence the association and dissociation dynamics of actin-binding proteins. Overall, our findings indicate that iomeprol can influence the structural and functional properties of actin, raising the possibility that such alterations may contribute to changes in actin organization and, consequently, to actin-dependent cellular processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.